A cross-sectional observational study of postoperative restricted antibiotic utilization, rationality, and cost analysis in a tertiary care teaching hospital

Shreya Gade; Aditya Dhumale; Uma A. Bhosale

doi:10.18203/2319-2003.ijbcp20252585

Authors

Shreya Gade SKNMC and GH, Narhe, Ambegaon, Pune, Maharashtra, India
Aditya Dhumale SKNMC and GH, Narhe, Ambegaon, Pune, Maharashtra, India
Uma A. Bhosale Department of Pharmacology, SKNMC and GH, Narhe, Ambegaon, Pune, Maharashtra, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20252585

Keywords:

AMR, Restricted antibiotics, Rationality, Cost analysis

Abstract

Background: Antimicrobial resistance (AMR) is an alarming condition that has been arising due to many interconnected factors, in particular, the use and misuse of antimicrobials. It is more prevalent in developing countries like India where there is a huge burden of infectious diseases. There has been insufficient research data to conclusively comment on the judicious use of antimicrobials. Therefore, this study is designed to assess the judicious use of antimicrobials on the basis of modified Kunin’s criteria and analyse the cost and its rationality.

Methods: Cross sectional observational study wherein patient data for last 2 year postoperative patients was analyzed.

Results: In the present study, a significant number of patients (82.76%) the restricted antimicrobials were used judiciously and majority of then (42.19%) incurred a cost of <10000 INR.

Conclusions: The study shows that with appropriate and strict measures it is possible to limit the use of restricted antimicrobials. This further helps to decrease emerging antimicrobial resistance and also decrease the cost incurred by the patients during their hospital stay.

Metrics

Metrics Loading ...

References

Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, et al. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health, Healthcare. 2023;11(13):1946. DOI: https://doi.org/10.3390/healthcare11131946

Almansour AM, Alhadlaq MA, Alzahrani KO, Mukhtar LE, Alharbi AL, Alajel SM. The Silent Threat: Antimicrobial-Resistant Pathogens in Food-Producing Animals and Their Impact on Public Health. Microorganisms. 2023;11(9):2127. DOI: https://doi.org/10.3390/microorganisms11092127

Ruckert A, Lake S, Van Katwyk SR. Developing a protocol on antimicrobial resistance through WHO’s pandemic treaty will protect lives in future pandemics. Global Health. 2024;20:10. DOI: https://doi.org/10.1186/s12992-024-01015-1

Ahmed SK, Hussein S, Qurbani K, Ibrahim RH, Fareeq A, Mahmood KA, et al. Antimicrobial resistance: Impacts, challenges, and future prospects. J Med Surg Public Health. 2024;2:100081. DOI: https://doi.org/10.1016/j.glmedi.2024.100081

Zaman SB, Hussain MA, Nye R, Mehta V, Mamun KT, Hossain N. A Review on Antibiotic Resistance: Alarm Bells are Ringing. Cureus. 2017;9(6):e1403. DOI: https://doi.org/10.7759/cureus.1403

Agyeman WY, Bisht A, Gopinath A, Cheema AH, Chaludiya K, Khalid M, et al. A Systematic Review of Antibiotic Resistance Trends and Treatment Options for Hospital-Acquired Multidrug-Resistant Infections. Cureus. 2022;14(10):e29956. DOI: https://doi.org/10.7759/cureus.29956

Chawla M, Verma J, Gupta R, Das B. Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance. Front Microbiol. 2022;13:887251. DOI: https://doi.org/10.3389/fmicb.2022.887251

Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309-18. DOI: https://doi.org/10.1179/2047773215Y.0000000030

Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229-41. DOI: https://doi.org/10.1177/2042098614554919

Jayalakshmi J, Priyadharshini MS. Restricting high-end antibiotics usage - challenge accepted! J Family Med Prim Care. 2019;8(10):3292-6. DOI: https://doi.org/10.4103/jfmpc.jfmpc_626_19

Khadse SN, Ugemuge S, Singh C. Impact of Antimicrobial Stewardship on Reducing Antimicrobial Resistance. Cureus. 2023;15(12):e49935. DOI: https://doi.org/10.7759/cureus.49935

Sannathimmappa MB. Antibiotic Stewardship to Combat Antimicrobial Resistance Menace: Present Updates, Challenges, and Future Directions. Clin Med Rev Case Rep. 2025;12:465. DOI: https://doi.org/10.23937/2378-3656/1410465

Adebisi YA. Balancing the risks and benefits of antibiotic use in a globalized world: The ethics of antimicrobial resistance. Global Health. 2023;19:27. DOI: https://doi.org/10.1186/s12992-023-00930-z

Kunin CM. Rational use of antibiotics / Calvin M. Kunin. WHO drug information. 1990;4(‎1)‎:4-7.

Singh AP, Gupta U, Das S. Monitor the use of antibiotics in intensive care units with special focus on restricted antibiotics in tertiary care hospital of India. Asian J Pharm Clin Res. 2016;9(1):256-9.